Close Menu

NEW YORK (GenomeWeb) – German start-up SpinDiag said on Thursday that it has raised €1.6 million ($1.9 million) in seed funding.

The financing came from three unnamed private investors and will be used to bring its point-of-care screening system to hospitals from its current laboratory environment, the firm said. The technology called SpinDiag one, is being developed for hospital screening of all clinically relevant antibiotic-resistant bacteria at the time patients are admitted.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.